Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

A new study funded by Eli Lilly reports that people without diabetes can lose up to 13% of their starting weight in 6 months ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Share on Pinterest Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight in the space of 6 months. Image credit: Tatsiana ...